(2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide

C128H159F2N25O17S5 — CID 158280436

IUPAC(2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide
SMILESCC(CCC1CC1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)c1ccccc1.CCC(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1snnc1-c1ccccc1)c1ccccc1.CCO[C@@H](C)[C@H](NC(=O)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)[C@H](C)OC.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Cc1snnc1-c1ccccc1)C1CCC(F)(F)CC1
InChIInChI=1S/C29H33N5O3S.C26H33F2N5O3S.C26H29N5O3S.C24H33N5O4S.C23H31N5O4S/c1-19(14-15-20-16-17-20)26(35)30-25(22-11-6-3-7-12-22)29(37)34-18-8-13-23(34)27(36)31-28-24(32-33-38-28)21-9-4-2-5-10-21;1-16(29-2)24(35)30-23(18-10-12-26(27,28)13-11-18)25(36)33-14-6-9-19(33)20(34)15-21-22(31-32-37-21)17-7-4-3-5-8-17;1-3-17(2)23(32)27-22(19-13-8-5-9-14-19)26(34)31-16-10-15-20(31)24(33)28-25-21(29-30-35-25)18-11-6-4-7-12-18;1-5-15(3)21(30)25-19(16(4)33-6-2)24(32)29-14-10-13-18(29)22(31)26-23-20(27-28-34-23)17-11-8-7-9-12-17;1-5-14(2)20(29)24-18(15(3)32-4)23(31)28-13-9-12-17(28)21(30)25-22-19(26-27-33-22)16-10-7-6-8-11-16/h2-7,9-12,19-20,23,25H,8,13-18H2,1H3,(H,30,35)(H,31,36);3-5,7-8,16,18-19,23,29H,6,9-15H2,1-2H3,(H,30,35);4-9,11-14,17,20,22H,3,10,15-16H2,1-2H3,(H,27,32)(H,28,33);7-9,11-12,15-16,18-19H,5-6,10,13-14H2,1-4H3,(H,25,30)(H,26,31);6-8,10-11,14-15,17-18H,5,9,12-13H2,1-4H3,(H,24,29)(H,25,30)/t19?,23-,25-;16-,19-,23-;;15-,16+,18+,19+;14-,15+,17+,18+/m00.11/s1
InChIKeyGKDMCXOUTFTXDH-GAEFGFGGSA-N
MW2518.17 g/mol
LogP17.87
Rot. Bonds46

About (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide

(2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide (PubChem CID 158280436) has the molecular formula C128H159F2N25O17S5 and a molecular weight of 2518.17 g/mol. Its IUPAC name is (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide
PubChem CID158280436
Molecular FormulaC128H159F2N25O17S5
Molecular Weight2518.17 g/mol
Exact Mass2516.09
IUPAC Name(2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide
SMILESCC(CCC1CC1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)c1ccccc1.CCC(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1snnc1-c1ccccc1)c1ccccc1.CCO[C@@H](C)[C@H](NC(=O)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)[C@H](C)OC.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Cc1snnc1-c1ccccc1)C1CCC(F)(F)CC1
InChIInChI=1S/C29H33N5O3S.C26H33F2N5O3S.C26H29N5O3S.C24H33N5O4S.C23H31N5O4S/c1-19(14-15-20-16-17-20)26(35)30-25(22-11-6-3-7-12-22)29(37)34-18-8-13-23(34)27(36)31-28-24(32-33-38-28)21-9-4-2-5-10-21;1-16(29-2)24(35)30-23(18-10-12-26(27,28)13-11-18)25(36)33-14-6-9-19(33)20(34)15-21-22(31-32-37-21)17-7-4-3-5-8-17;1-3-17(2)23(32)27-22(19-13-8-5-9-14-19)26(34)31-16-10-15-20(31)24(33)28-25-21(29-30-35-25)18-11-6-4-7-12-18;1-5-15(3)21(30)25-19(16(4)33-6-2)24(32)29-14-10-13-18(29)22(31)26-23-20(27-28-34-23)17-11-8-7-9-12-17;1-5-14(2)20(29)24-18(15(3)32-4)23(31)28-13-9-12-17(28)21(30)25-22-19(26-27-33-22)16-10-7-6-8-11-16/h2-7,9-12,19-20,23,25H,8,13-18H2,1H3,(H,30,35)(H,31,36);3-5,7-8,16,18-19,23,29H,6,9-15H2,1-2H3,(H,30,35);4-9,11-14,17,20,22H,3,10,15-16H2,1-2H3,(H,27,32)(H,28,33);7-9,11-12,15-16,18-19H,5-6,10,13-14H2,1-4H3,(H,25,30)(H,26,31);6-8,10-11,14-15,17-18H,5,9,12-13H2,1-4H3,(H,24,29)(H,25,30)/t19?,23-,25-;16-,19-,23-;;15-,16+,18+,19+;14-,15+,17+,18+/m00.11/s1
InChIKeyGKDMCXOUTFTXDH-GAEFGFGGSA-N
XLogP17.87
TPSA539.91 Ų
H-Bond Donors10
H-Bond Acceptors33
Rotatable Bonds46
Heavy Atoms177
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002518.17
LogP ≤ 517.87
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1033

Analyze (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide?
The IUPAC name of (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide (CID 158280436) is (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide.
What is the SMILES notation for (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide?
The canonical SMILES for (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide is CC(CCC1CC1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)c1ccccc1.CCC(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1snnc1-c1ccccc1)c1ccccc1.CCO[C@@H](C)[C@H](NC(=O)[C@H](C)CC)C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1.CC[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)[C@H](C)OC.CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Cc1snnc1-c1ccccc1)C1CCC(F)(F)CC1.
What is the InChIKey of (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide?
The InChIKey is GKDMCXOUTFTXDH-GAEFGFGGSA-N. The full InChI is InChI=1S/C29H33N5O3S.C26H33F2N5O3S.C26H29N5O3S.C24H33N5O4S.C23H31N5O4S/c1-19(14-15-20-16-17-20)26(35)30-25(22-11-6-3-7-12-22)29(37)34-18-8-13-23(34)27(36)31-28-24(32-33-38-28)21-9-4-2-5-10-21;1-16(29-2)24(35)30-23(18-10-12-26(27,28)13-11-18)25(36)33-14-6-9-19(33)20(34)15-21-22(31-32-37-21)17-7-4-3-5-8-17;1-3-17(2)23(32)27-22(19-13-8-5-9-14-19)26(34)31-16-10-15-20(31)24(33)28-25-21(29-30-35-25)18-11-6-4-7-12-18;1-5-15(3)21(30)25-19(16(4)33-6-2)24(32)29-14-10-13-18(29)22(31)26-23-20(27-28-34-23)17-11-8-7-9-12-17;1-5-14(2)20(29)24-18(15(3)32-4)23(31)28-13-9-12-17(28)21(30)25-22-19(26-27-33-22)16-10-7-6-8-11-16/h2-7,9-12,19-20,23,25H,8,13-18H2,1H3,(H,30,35)(H,31,36);3-5,7-8,16,18-19,23,29H,6,9-15H2,1-2H3,(H,30,35);4-9,11-14,17,20,22H,3,10,15-16H2,1-2H3,(H,27,32)(H,28,33);7-9,11-12,15-16,18-19H,5-6,10,13-14H2,1-4H3,(H,25,30)(H,26,31);6-8,10-11,14-15,17-18H,5,9,12-13H2,1-4H3,(H,24,29)(H,25,30)/t19?,23-,25-;16-,19-,23-;;15-,16+,18+,19+;14-,15+,17+,18+/m00.11/s1.
What are the key properties of (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide?
(2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide has a molecular weight of 2518.17 g/mol, XLogP of 17.87, 46 rotatable bonds, 10 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-1-[(2S)-2-[(4-cyclopropyl-2-methylbutanoyl)amino]-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-N-[(1S)-1-(4,4-difluorocyclohexyl)-2-oxo-2-[(2S)-2-[2-(4-phenylthiadiazol-5-yl)acetyl]pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide;(2S)-1-[(2S,3S)-3-ethoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;(2S)-1-[(2S,3S)-3-methoxy-2-[[(2R)-2-methylbutanoyl]amino]butanoyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide;1-[2-(2-methylbutanoylamino)-2-phenylacetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide is sourced from PubChem (CID 158280436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).